New York Life Investment Management LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 16.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 27,069 shares of the semiconductor company’s stock after acquiring an additional 3,829 shares during the period. New York Life Investment Management LLC’s holdings in Synopsys were worth $13,356,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. Alpine Bank Wealth Management grew its position in Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. grew its holdings in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after acquiring an additional 50 shares during the period. Millstone Evans Group LLC purchased a new stake in Synopsys during the third quarter valued at $27,000. SOA Wealth Advisors LLC. bought a new position in Synopsys in the third quarter valued at about $28,000. Finally, McIlrath & Eck LLC purchased a new position in Synopsys in the third quarter worth about $29,000. 85.47% of the stock is currently owned by institutional investors.
Synopsys Trading Up 2.8%
Shares of SNPS opened at $438.90 on Tuesday. The firm has a market cap of $83.97 billion, a P/E ratio of 54.93, a price-to-earnings-growth ratio of 3.56 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a 50 day simple moving average of $479.34 and a two-hundred day simple moving average of $493.86.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on SNPS. JPMorgan Chase & Co. raised their price objective on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Morgan Stanley raised their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. KeyCorp boosted their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Finally, Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $553.57.
View Our Latest Stock Report on Synopsys
Insider Transactions at Synopsys
In other news, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last quarter. 0.62% of the stock is owned by company insiders.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
